# Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects

> **NCT07240116** · PHASE1 · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Miricorilant Treatment A
- **DRUG:** Miricorilant Treatment B
- **DRUG:** Miricorilant Treatment C
- **DRUG:** Miricorilant Treatment D

## Key facts

- **NCT ID:** NCT07240116
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-11
- **Primary completion:** 2026-03-03
- **Final completion:** 2026-03-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07240116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07240116, "Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07240116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*